{"id":"W2142482664","doi":"10.1086/590566","title":"Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria","year":2008,"lang":"en","type":"review","venue":"Clinical Infectious Diseases","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":460,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Institutes of Health; Astellas Pharma; Gilead Sciences; Steadman Philippon Research Institute; Eisai; Pfizer; Amgen","keywords":"Medicine; Clinical trial; Coccidioides; Coccidioides immitis; Intensive care medicine; Antifungal; Cryptococcus neoformans; Aspergillosis; Cryptococcosis; Cancer; Histoplasma; Disease; Histoplasmosis; Pathology; Immunology; Internal medicine; Histoplasma capsulatum; Dermatology; Biology; Microbiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004509949,0.0004288963,0.005226183,0.0003813509,0.0001738774,0.00004589076,0.00009878769,0.0001837854,0.00001892686],"category_scores_gemma":[0.05047492,0.0002874659,0.000473384,0.0004595564,0.0008186504,0.00004265229,0.0001539048,0.0002456264,0.00000101741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009590785,"about_ca_system_score_gemma":0.0007795091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001914277,"about_ca_topic_score_gemma":0.0005576237,"domain_scores_codex":[0.9861532,0.008750338,0.003496709,0.0009961302,0.0003235551,0.0002800766],"domain_scores_gemma":[0.9613888,0.03622419,0.0008388713,0.0005393875,0.0005383973,0.0004703484],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002352916,0.01171299,0.7311637,0.001402114,0.0008861869,0.00007891458,0.0002505144,2.883322e-8,4.585451e-7,0.000006541936,0.00006194998,0.2520836],"study_design_scores_gemma":[0.008300564,0.02473728,0.9602406,0.00213046,0.002027678,0.000005619527,0.0009018839,3.271059e-7,3.690159e-7,0.00002434137,0.001417393,0.0002135068],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.5407014,0.4539239,6.15263e-7,0.00001526314,0.00008748285,0.00468344,0.0005672295,0.00001766973,0.000002944697],"genre_scores_gemma":[0.452328,0.5473138,0.000006495752,0.00002168599,0.00009184673,0.000139651,0.00003861456,0.00004105892,0.00001884559],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.2518701,"threshold_uncertainty_score":0.9999577,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4496080110103085,"score_gpt":0.5926173956961437,"score_spread":0.1430093846858352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}